Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL

Lan V Pham, PhD, Archito T. Tamayo, MS, Elizabeth Pogue, Gary Lu, MD, Pramoda Challagundla, Jeffrey L. Jorgensen, MD PhD, Liang Zhang, MD PhD, Michael Wang, MD, Richard J. Ford, MD PhD

Blood (2014) 124 (21): 494.

https://doi.org/10.1182/blood.V124.21.494.494

Published: 2014

Journal Articles

Clinical Characteristics and Outcomes in Patients with Multiple Myeloma and CKS1B Gene Gain/Amplification after Autologous Stem Cell Transplantation

Fabian M Bock, Gary Lu, MD, Nina Shah, Qaiser Bashir, Krina K. Patel, MD, Uday R. Popat, MD, Chitra M. Hosing, Sameh Gaballa, MD, Martin Korbling, MD, Ruby Delgado, Gabriela Rondon, MD, Robert Z. Orlowski, MD, PhD, Jatin J. Shah, Elisabet E. Manasanch, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2014) 124 (21): 2521.

https://doi.org/10.1182/blood.V124.21.2521.2521

Published: 2014

Journal Articles

C-MYC Rearrangement: A Marker for High-Risk Myeloma

Isabella C. Glitza, MD, PhD, Gary Lu, MD, Su Chen, MD, PhD, Robert Z. Orlowski, M.D., Ph.D., Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 4989.

https://doi.org/10.1182/blood.V120.21.4989.4989

Published: 2012

Journal Articles

Acquired Therapy-Related Cytogenetic Clones in Patients Treated for Multiple Myeloma

Hans C. Lee, MD, C. Cameron Yin, MD, PhD, Muzaffar H. Qazilbash, MD, Iris Wang, MD, Victoria Lu, Gary Lu, MD

Blood (2012) 120 (21): 4059.

https://doi.org/10.1182/blood.V120.21.4059.4059

Published: 2012

Journal Articles

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Sairah Ahmed, MD, Heather Lin, PhD, Veera Baladandayuthapani, PhD, Mubeen A Khan, Gary Lu, MD, Gabriela Rondon, MD, Sofia Qureshi, Yvonne T Dinh, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Chitra M Hosing, MD, Uday Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 333.

https://doi.org/10.1182/blood.V118.21.333.333

Published: 2011

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

Clinical Features of Patients with Multiple Myeloma and C-MYC Rearrangements

Isabella C. Glitza, MD, PhD, Gary Lu, MD, Su Chen, MD, PhD, Robert Z. Orlowski, MD, PhD, Muzaffar Qazilbash, MD

Blood (2011) 118 (21): 5090.

https://doi.org/10.1182/blood.V118.21.5090.5090

Published: 2011

Journal Articles

Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma

Ling Chen, Yaling Yang, PhD, C. Cameron Yin, MD, PhD, Gary Lu, MD, Su Chen, MD, PhD, Xiaoyan Huang, MD., MS, Jiayu Chen, PhD, Felix Chang, Effie Rahman, Steliana Calin, MD, L. Jeffrey Medeiros, MD, Roberto N. Miranda, MD, M. James You, MD, PhD

Blood (2011) 118 (21): 4633.

https://doi.org/10.1182/blood.V118.21.4633.4633

Published: 2011

Journal Articles

Frequent Epigenetic Inactivation of MSX2 In Acute Myeloid Leukemia

Chen Zhao, MD, PhD, Xin Han, MD, MS, Yu H. Zhang, MD, Xiaoyan Huang, MD., MS, Aili Dai, MS, Gary Lu, MD, C. Cameron Yin, MD, PhD, Ling Chen, M. James You, MD, PhD

Blood (2010) 116 (21): 4645.

https://doi.org/10.1182/blood.V116.21.4645.4645

Published: 2010

NARROW

The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL

Clinical Characteristics and Outcomes in Patients with Multiple Myeloma and CKS1B Gene Gain/Amplification after Autologous Stem Cell Transplantation

C-MYC Rearrangement: A Marker for High-Risk Myeloma

Acquired Therapy-Related Cytogenetic Clones in Patients Treated for Multiple Myeloma

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Clinical Features of Patients with Multiple Myeloma and C-MYC Rearrangements

Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma

Frequent Epigenetic Inactivation of MSX2 In Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only